-
1.发明授权SUBSTITUTED 5-CARBOXYAMIDE PYRAZOLES AND [1,2,4]TRIAZOLES AS ANTIVIRAL AGENTS 有权取代的5-羧酰胺吡唑和作为抗病毒剂的[1,2,4]三唑
公开(公告)号：EP1814860B1
公开(公告)日：2009-06-03
申请号：EP05824911.1
申请日：2005-10-26
申请人： Schering Corporation
发明人： SHIPPS, Gerald, W., Jr. , CURRAN, Patrick, J. , ANNIS, D., Allen , NASH, Huw, M. , COOPER, Alan, B. , ZHU, Hugh, Y. , WANG, James, J-S. , DESAI, Jagdish, A. , GIRIJAVALLABHAN, Viyyoor, Moopil
IPC分类号： C07D231/14 , A61K31/415 , A61P31/14
CPC分类号： C07D249/10 , C07D231/14 , C07D231/40 , C07D231/42 , C07D401/06 , C07D401/12 , C07D403/04 , C07D403/06 , C07D403/12 , C07D405/12 , C07D409/12
摘要： The present invention provides compounds of formula I wherein X, Y, R1-R7 are as defined herein. Compositions containing these compounds, and methods for inhibiting HCV RNA-dependent RNA polymerase and treating hepatitis C and related disorders using these compounds and compositions are also provided. (I)
摘要翻译： 本发明提供了式I的化合物，其中X，Y，R 1 -R 7如本文所定义。 还提供了包含这些化合物的组合物，以及用于抑制HCV RNA依赖性RNA聚合酶并使用这些化合物和组合物治疗丙型肝炎及相关病症的方法。 （一世）
-
2.发明公开SUBSTITUTED 5-CARBOXYAMIDE PYRAZOLES AND [1,2,4]TRIAZOLES AS ANTIVIRAL AGENTS 有权取代的5- CARBOXYAMIDPYRAZOLES AND [1,2,4]三唑ALS的杀病毒
公开(公告)号：EP1814860A1
公开(公告)日：2007-08-08
申请号：EP05824911.1
申请日：2005-10-26
申请人： SCHERING CORPORATION
发明人： SHIPPS, Gerald, W., Jr. , CURRAN, Patrick, J. , ANNIS, D., Allen , NASH, Huw, M. , COOPER, Alan, B. , ZHU, Hugh, Y. , WANG, James, J-S. , DESAI, Jagdish, A. , GIRIJAVALLABHAN, Viyyoor, Moopil
IPC分类号： C07D231/14 , A61K31/415 , A61P31/14
CPC分类号： C07D249/10 , C07D231/14 , C07D231/40 , C07D231/42 , C07D401/06 , C07D401/12 , C07D403/04 , C07D403/06 , C07D403/12 , C07D405/12 , C07D409/12
摘要： The present invention provides compounds of formula I wherein X, Y, R1-R7 are as defined herein. Compositions containing these compounds, and methods for inhibiting HCV RNA-dependent RNA polymerase and treating hepatitis C and related disorders using these compounds and compositions are also provided. (I)
-
搜索结果
2 条记录 (耗时 0.009 秒)
